A - Agilent Technologies, Inc.
64.99 0.00 (0.00%)
After hours: 4:30PM EST
| Previous Close | 64.72 |
| Open | 64.38 |
| Bid | 64.20 x 1400 |
| Ask | 65.34 x 800 |
| Day's Range | 64.38 - 65.60 |
| 52 Week Range | 60.42 - 75.00 |
| Volume | 2,957,797 |
| Avg. Volume | 2,422,804 |
| Market Cap | 20.717B |
| Beta (3Y Monthly) | 1.36 |
| PE Ratio (TTM) | 71.18 |
| EPS (TTM) | 0.91 |
| Earnings Date | Nov 19, 2018 |
| Forward Dividend & Yield | 0.60 (0.92%) |
| Ex-Dividend Date | 2018-10-01 |
| 1y Target Est | 79.08 |
- Business Wire•6 hours ago
Agilent Expands Cell Analysis R&D Capabilities in Ireland
The expanded state-of-the-art facility incorporates recently acquired Luxcel Biosciences, adding real-time, fluorescence plate reader-based in vitro cell assay kits to Agilent’s cell analysis portfolio. The complex will house two new laboratories, one dedicated to cell analysis technologies, and the other to develop biosensors and related bio assay solutions. Agilent entered the cell analysis market in 2015 with the acquisition of Seahorse Bioscience, a leader in the development of specialized instruments and live-cell, kinetic assays.
- Zacks•yesterday
Will New Technologies Benefit Agilent (A) in Q4 Earnings?
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal fourth-quarter 2018 results.
- Business Wire•2 days ago
Agilent Completes Acquisition of ACEA Biosciences
Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis tools, for $250 million in cash. This acquisition brings together two pioneers in cellular function and metabolism measurements focused on real-time, live cell analyses. ACEA has developed two ground-breaking platforms that are complementary to Agilent’s current portfolio.
- Business Wire•2 days ago
Agilent Technologies Increases Cash Dividend to 16.4 Cents per Share
Agilent Technologies Inc. (NYSE:A) today announced that its board of directors has increased the company’s quarterly dividend to 16.4 cents per share of common stock. Agilent Technologies Inc. (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions.
Markit•2 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- Business Wire•4 days ago
Agilent Technologies to Present at Evercore ISI HealthCONx
Agilent Technologies Inc. today announced the following webcast for the investment community:
- Zacks•4 days ago
Agilent Technologies (A) Earnings Expected to Grow: Should You Buy?
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- MarketWatch•6 days ago
Biotech stocks have been hit hard — here are ones analysts like best for a rebound
Nine companies have majority ‘buy’ ratings, with upside potential of as much as 123%, according to analysts.
Markit•7 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- Business Wire•10 days ago
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Align Technology, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Align Technology, Inc. (“Align” or “the Company”) (NASDAQ: ALGN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between July 25, 2018 and October 24, 2018, inclusive (the “Class Period”), are encouraged to contact the firm before January 4, 2019. We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge.
Markit•10 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- Motley Fool•11 days ago
Twist Bioscience IPO: What Investors Need to Know
Investors can now buy shares in a leading synthetic biology company. But should they?
- Business Wire•14 days ago
Agilent Introduces New ICP-MS Water Analyzer Solution
Fully integrated solution increases productivity of environmental labs
- Business Wire•15 days ago
Agilent Introduces Groundbreaking UV-Vis Spectrophotometer for Pharmaceutical, Biomedical, and Academic Laboratories
Agilent Technologies Inc. (NYSE:A) today introduced the Cary 3500 UV-Vis system, an innovative spectrophotometer designed to help life science, pharma and biopharma research communities simplify their analyses, optimize laboratory productivity, and ultimately help bring new therapeutics to market faster. Agilent will showcase the Cary 3500 UV-Vis system at analytica China, being held October 31 – November 2, 2018, in Shanghai, China.
- Business Wire•16 days ago
Agilent Introduces Unique Next Generation Sequencing-based Preimplantation Genetic Testing (PGT) Solution
Agilent Technologies Inc. (NYSE:A) today announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution for preimplantation genetic testing (PGT). Agilent will showcase the OnePGT solution at the 5th Congress on Controversies in Preconception, Preimplantation and Prenatal Genetic Diagnosis (CoGEN), November 1-3, 2018 in Paris, France. This innovative solution provides fertility specialists the ability to more easily achieve comprehensive PGT data in which to support enhanced embryo ranking, identifying the best quality embryos for transfer.
- GlobeNewswire•16 days ago
Analysis: Positioning to Benefit within At Home Group, Synopsys, Agilent Technologies, AGNC Investment, Helios and Matheson Analytics, and Tech Data — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Oct. 31, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Markit•16 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- Business Wire•18 days ago
Agilent Sends Letter to the SEC Regarding Material Misstatements in Twist Bioscience’s S-1 Registration Statement
Agilent Technologies Inc. (NYSE:A) today announced that it sent a letter to the Division of Corporation Finance of the U.S. Securities and Exchange Commission (SEC) regarding misstatements in the S-1 Registration Statement filed by Twist Bioscience Corp. Ms. Leproust admitted under oath that she secretly became Twist’s CEO 17 months prior to leaving Agilent.
- Business Wire•21 days ago
Agilent Welcomes New Senior Vice President of Corporate Development
Agilent Technologies Inc. (NYSE:A) is pleased to announce Eric Gerber as the company’s new senior vice president of strategy and corporate development, reporting to Agilent President and CEO, Mike McMullen, effective November 1, 2018. Gerber will lead the corporate development team in identifying, developing and evaluating M&A plans globally while collaborating with the businesses groups to help drive critical growth initiatives across the company.
- Business Wire•22 days ago
Passionate and Dedicated Employees Earn Agilent Recognition by Forbes as a World’s Best Employer
Agilent Technologies Inc. (NYSE:A) today announced that it has been recognized by Forbes as one of the World’s Best Employers. This marks the second consecutive year that Agilent has been named to this elite global list. Agilent is ranked number 125 of the 500 companies on the list.
- American City Business Journals•23 days ago
West Sacramento Bayer CoLaborator fills up with New Zealand company
A New Zealand company working to develop ultraviolet light as an agricultural tool is the third tenant in the Bayer Crop Science CoLaborator in West Sacramento.
- Investopedia•23 days ago
8 Overlooked Stocks Poised For Big Contrarian Gains
With the stock market engulfed in turmoil and increased volatility, investors may be on the lookout for stocks that can deliver big short-term gains. Morgan Stanley names 8 stocks for which they have high conviction about a positive near term view: Tesla Inc. ( TSLA), Zendesk Inc. ( ZEN), SBA Communications Corp. ( SBAC), Molina Healthcare Inc. ( MOH), FirstEnergy Corp. ( FE), CyberArk Software Ltd. ( CYBR), Bausch Health Companies Inc. ( BHC) and Agilent Technologies Inc. ( A). The key catalysts that Morgan Stanley sees for upside in these stocks are summarized in the table below.
- Business Wire•23 days ago
Agilent Technologies to Host Webcast of Fourth-Quarter Fiscal Year 2018 Financial Results Conference Call
Agilent Technologies Inc. will release fourth-quarter fiscal 2018 financial results after the stock market closes on November 19. The company will host a live webcast of its investor conference call in listen-only mode.
Markit•27 days agoSee what the IHS Markit Score report has to say about Agilent Technologies Inc.
Agilent Technologies Inc NYSE:A
- Simply Wall St.•28 days ago
When Should You Buy Agilent Technologies Inc (NYSE:A)?
Today we’re going to take a look at the well-established Agilent Technologies Inc (NYSE:A). The company’s stock received a lot of attention from a substantial price movement on the NYSE Read More...
